StockWatch
·
Healthcare Service Provider
Quarterly Result3 Jun 2026, 09:31 pm

Dr Lalchandani Labs Approves Audited FY26 Results

AI Summary

Dr Lalchandani Labs Ltd announced the approval of its audited standalone financial results for the half-year and full year ended March 31, 2026. The Board of Directors also approved the appointment of M/s. Brickwork Ratings India Private Limited as the new Monitoring Agency for the utilization of Rights Issue Proceeds, replacing M/s. Infomerics Valuation and Ratings Limited. The company reported a net profit before tax adjustment of ₹76.46 Lacs from operating activities and a net cash flow from financing activities of ₹211.74 Lacs, resulting in an increase in cash and cash equivalents to ₹414.08 Lacs.

Key Highlights

  • Audited standalone financial results for FY26 approved.
  • New Monitoring Agency appointed for Rights Issue Proceeds.
  • Net cash flow from financing activities was ₹211.74 Lacs.
  • Cash and cash equivalents increased to ₹414.08 Lacs.
  • Company entered into an One Time Settlement (OTS) scheme for unsecured loans.
DLCL
Healthcare Service Provider
Dr Lalchandani Labs Ltd

Price Impact